Zevin Robert Brooke Associates

Brook Venture, now known as 424 Capital, is an investment firm based in Wakefield, MA, dedicated to providing capital to expansion stage businesses. The firm positions itself as a hands-on partner, supporting companies in their growth through strategic investments and corporate development services. With a focus on building market leaders, Brook Venture has facilitated significant acquisitions in the healthcare and education sectors, including Instructure's acquisition of Certica Solutions and RLDatix's acquisition of Verge Health. The company's rebranding reflects its commitment to aligning with its strategic goals and enhancing its role in fostering business success. Generated from the website

Inotek Pharmaceuticals is a privately held biotechnology company based in Lexington, MA, specializing in the discovery and development of innovative treatments for serious ocular diseases. With a robust pipeline focusing on conditions such as glaucoma and age-related macular degeneration, the company employs a scientifically rigorous approach to advance its lead drug candidate, trabodenoson INO-8875, which effectively addresses elevated intraocular pressure. The firm is supported by an experienced management team with a proven track record of successful New Drug Applications (NDAs), aiming to bring its clinical programs to commercialization. In addition to its advanced drug development platform, Inotek offers a range of effective, over-the-counter eye drops for glaucoma, ensuring high-quality products through collaboration with official suppliers and manufacturers. Generated from the website